文献速递湿疹皮炎与荨麻疹

美国慢性荨麻疹患病率:性别和年龄调整的人群分析

Prevalence estimates for chronic urticaria in the United States: A sex- and age-adjusted population analysis.
PubMed 文献 · J Am Acad Dermatol · 2019-03-11

女性患病率(每10万310例)超过男性(每10万146例)的两倍,患病率在40-49岁和50-59岁年龄组最高,黑种人和其他种族调整后患病率高于白种人。

要点

  • 美国成人慢性荨麻疹总体患病率为0.23%(230例/10万成人)。
  • 女性患病率(310/10万)显著高于男性(146/10万)。
  • 40-59岁年龄段患病率最高,黑种人和其他种族高于白种人。

核心结论

  • 美国估计有超过50万人患有慢性荨麻疹,其中大多数为女性或40岁及以上成人。

主要发现

  • 总体慢性荨麻疹患病率为0.23%,即每10万成人中230例。

局限性

  • 使用行政数据可能低估疾病负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Disease burden in chronic urticaria (CU) is poorly understood. OBJECTIVE: To estimate standardized overall and sex-, age-, and race-specific prevalence estimates for CU among adults in the United States. METHODS: A cross-sectional analysis with electronic health records data for a demographically heterogeneous population-based sample of >55 million patients across all 4 census regions. RESULTS: The overall CU prevalence was 0.23%, or 230 CU cases/100,000 adults. The adjusted prevalence in women was 310 (95% confidence interval [CI] 307-312) cases/100,000 adults, more than twice that of men (146 [95% CI 143-148] cases/100,000 adults, P < .001). CU prevalence was highest among patients aged 40-49 years (256 [95% CI 252-261] cases/100,000 adults) and 50-59 years (246 [95% CI 242-251] cases/100,000 adults) compared with all other age groups (P < .0001). Adjusted prevalences for black (292 [95% CI 285-298] cases/100,000 adults) and other (331 [95% CI 323-338] cases/100,000 adults) patients were higher than that for white patients (262 [95% CI 260-264] cases/100,000 adults; P < .001). LIMITATIONS: Use of administrative data has the potential to underestimate burden. CONCLUSION: There are >500,000 people estimated to have CU in the United States, most of whom are women or adults ≥40 years of age.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Wertenteil S, Strunk A, Garg A, et al. Prevalence estimates for chronic urticaria in the United States: A sex- and age-adjusted population analysis. J Am Acad Dermatol. 2019. PMID: 30872154. doi:10.1016/j.jaad.2019.02.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。